Evidence map›Paper›PMID 35326449›Full record

ReviewCells2022

Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions.

Saleh Jamehdor, Sara Pajouhanfar, Sadaf Saba, Georges Uzan, Ali Teimoori, Sina Naserian

Abstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Saleh JamehdorCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 989155432609, Iran.
Sara PajouhanfarDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Sadaf SabaCenter for Molecular Medicine & Genetics, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Georges UzanINSERM UMR-S-MD 1197, Hôpital Paul Brousse, 94800 Villejuif, France.
Ali TeimooriDepartment of Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan 6517838738, Iran.
Sina NaserianINSERM UMR-S-MD 1197, Hôpital Paul Brousse, 94800 Villejuif, France.ORCID 0000-0003-3604-8375

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viruses are one of the most important concerns for human health, and overcoming viral infections is a worldwide challenge. However, researchers have been trying to manipulate viral genomes to overcome various disorders, including cancer, for vaccine development purposes. CRISPR (clustered regularly interspaced short palindromic repeats) is becoming one of the most functional and widely used tools for RNA and DNA manipulation in multiple organisms. This approach has provided an unprecedented opportunity for creating simple, inexpensive, specific, targeted, accurate, and practical manipulations of viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human immunodeficiency virus-1 (HIV-1), and vaccinia virus. Furthermore, this method can be used to make an effective and precise diagnosis of viral infections. Nevertheless, a valid and scientifically designed CRISPR system is critical to make more effective and accurate changes in viruses. In this review, we have focused on the best and the most effective ways to design sgRNA, gene knock-in(s), and gene knock-out(s) for virus-targeted manipulation. Furthermore, we have emphasized the application of CRISPR technology in virus diagnosis and in finding significant genes involved in virus-host interactions.

Indexed as

COVID-19Virus DiseasesVirusesClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsDNA VirusesHost Microbial InteractionsHumansSARS-CoV-2CRISPRgenetic engineeringHIV-1SARS-CoV-2virus

Identifiers

PMID35326449
PMCPMC8946942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.